Precision Medicine in Oncology 2020
DOI: 10.1002/9781119432487.ch1
|View full text |Cite
|
Sign up to set email alerts
|

Genomic Strategies for Personalized Cancer Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 362 publications
0
0
0
Order By: Relevance
“…Additionally, studies have explored the correlation between specific morphological features and microsatellite instability (MSI) status in UCEC, shedding light on the presence of APC pathogenic mutations in this context [46,47]. Furthermore, investigations have also investigated germline pathogenic mutations in CDH1 gene and their implications in hereditary diffuse gastric cancer, which also has implications for UCEC given CDH1 mutations' broader significance [48,49].…”
Section: Drug Prediction Analysis Outcomesmentioning
confidence: 99%
“…Additionally, studies have explored the correlation between specific morphological features and microsatellite instability (MSI) status in UCEC, shedding light on the presence of APC pathogenic mutations in this context [46,47]. Furthermore, investigations have also investigated germline pathogenic mutations in CDH1 gene and their implications in hereditary diffuse gastric cancer, which also has implications for UCEC given CDH1 mutations' broader significance [48,49].…”
Section: Drug Prediction Analysis Outcomesmentioning
confidence: 99%